| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.47 | 0.001 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |